Clinical Trial Update: A Study of Barzolvolimab in Patients With Atopic Dermatitis [Phase 2]

View source ↗

Summary

This entry covers a Phase 2 clinical trial of Barzolvolimab for atopic dermatitis. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Barzolvolimab (barzolvolimab)

Snippet

Sponsor: Celldex Therapeutics | Conditions: Atopic Dermatitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING